Sage Journals: Discover world-class research

Open access

Research article

First published 2019

Coagulation Factor Xa (Recombinant),Inactivated-Zhzo (Andexanet Alfa) Hemostatic Outcomes and Thrombotic Event Incidence at an Academic Medical Center

Victoria M. Stevens, Toby Trujillo, Scott W. Mueller [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2025

Risk Factors Associated with Thrombus Development Following Pharmacologic Anticoagulation Reversal with Coagulation Factor Xa [Recombinant],Inactivated-zhzo

David Zingale, Raymond Lamore, Derek Peiffer [...]

Hospital Pharmacy

Retricted access

Review article

First published 2018-10

Coagulation Factor Xa (Recombinant),Inactivated-zhzo (Andexanet Alfa)

Danial E. Baker

Hospital Pharmacy

Retricted access

Research article

First published 2020-8

A Systematic and Evidence-Based Review of Published and Pending Reports of Andexanet Alfa

Thomas M. Ellington

Journal of Pharmacy Practice

Open access

Research article

First published 2021

Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding

Victoria M. Stevens, Toby C. Trujillo, Tyree H. Kiser [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2024

Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine,Ovine and Porcine Origin Almost as Protamine Sulfate

Fakiha Siddiqui, Debra Hoppensteadt, Walter Jeske [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2013-2

Contemporary Anticoagulation Reversal

Erin E. Mancl, Alexis N. Crawford, Stacy A. Voils

Journal of Pharmacy Practice

Retricted access

Brief report

First published 2022-4

Difficulties Detecting Clinically Relevant Factor Xa Inhibitor Levels Prior to Reversal With Andexanet Alfa for Intracranial Hemorrhage

Sarah Elizabeth B. Davis, Kelly A. Dehne, Clio A. Rubinos [...]

The Neurohospitalist

Open access

Research article

First published 2019

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values

Fakiha Siddiqui, Alfonso Tafur, Lorenzo Storino Ramacciotti [...]

Clinical and Applied Thrombosis/Hemostasis

Search results